Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

12.75p
   
  • Change Today:
    -0.25p
  • 52 Week High: 14.50
  • 52 Week Low: 5.63
  • Currency: UK Pounds
  • Shares Issued: 444.23m
  • Volume: 213,843
  • Market Cap: £56.64m
  • Beta: 0.01

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

Key Personnel

CEO: Carolyn Cross
CFO and COO: Michael S. Behlke
Chairman: Jean Charest
Chief Technology Officer: Nicolas Loebel
Independent Non-Executive Director: Junaid Bajwa
Independent Non-Executive Director: Simon Sinclair
Interim CFO: Kwong Choo
Senior Independent Non-Executive Director: Jean Duvall
Non-Executive Dir: Craig Tooman

Contact Details

Address: 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6
Phone: +1 604 669 0555
Website: https://ondinebio.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: CA68234M2058

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 12.75p
Change Today -0.25p
% Change -1.92 %
52 Week High 14.50
52 Week Low 5.63
Volume 213,843
Shares Issued 444.23m
Market Cap £56.64m
Beta 0.01

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.03% below the market average70.03% below the market average70.03% below the market average70.03% below the market average70.03% below the market average
95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average
Price Trend
10.87% above the market average10.87% above the market average10.87% above the market average10.87% above the market average10.87% above the market average
64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average
Income Not Available
Growth
41.69% above the market average41.69% above the market average41.69% above the market average41.69% above the market average41.69% above the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average

OBI Dividends

No dividends found

Trades for 08-Aug-2025

Time Volume / Share Price
13:06 78,835 @ 12.70p
12:04 100,000 @ 13.00p
12:01 35,000 @ 13.30p
09:47 8 @ 12.50p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page